A wide range of signals, many of which are thought to be related to cellular stress, induce expression of early response genes through the NF-B family of transcription factors (1-4). In resting cells, NF-B is retained in cytoplasm in its inactive form by interaction with one of a number of inhibitory molecules including IB␣, IB, IB⑀, p105, and p100. Activation of the NF-B signaling cascade results in a complete degradation of IB or carboxyl-terminal partial degradation of the p105 and p100 precursors, allowing nuclear translocation of the NF-B complexes. Activated NF-B binds to specific DNA sequences in target genes, designated as B elements, and regulates transcription of genes mediating inflammation, carcinogenesis, and pro-or antiapoptotic reactions. IB␣ is the most abundant inhibitory protein for NF-B (5). The mechanisms of signalinduced IB␣ degradation involve phosphorylation of two serine residues, Ser 32 and Ser 36 . This phosphorylation leads to polyubiquitination of two specific lysines on IB␣ (Lys 21 and Lys 22 ) by an SCF--TrCP complex and its degradation by the 26 S proteasome (6). The phosphorylation is accomplished by a specific IB kinase (IKK) 1 complex containing two catalytic subunits, IKK␣ and IKK, and a structural component named NEMO/IKK␥/IKKAP (3, 5). IKK␣ and IKK share 50% sequence homology. Both proteins contain an amino-terminal kinase domain, a carboxyl-terminal region with a leucine zipper, and a helix-loop-helix domain. In vitro and in vivo studies indicate that both IKK␣ and IKK are capable of phosphorylating IB␣ on Ser 32 and Ser 36 , but IKK is more potent in IB␣ phosphorylation induced by proinflammatory stimuli. Recent studies by several groups indicate the existence of an additional IKK-like kinase complex in T cells, named IKKi/⑀, which shares 27% homology with IKK␣ and IKK and possibly mediates NF-B-activating kinase signaling and phorbol 12-myristate 13-acetate/protein kinase C⑀-induced Ser 36 phosphorylation of IB␣ and thus NF-B activation (7-11).